Nelfinavir inhibits maturation and export of herpes simplex virus 1

Nene N. Kalu, Prashant Desai, Courtney M. Shirley, D Wade Gibson, Phillip A. Dennis, Richard F Ambinder

Research output: Contribution to journalArticle

Abstract

Nelfinavir (NFV) is an HIV-1 protease inhibitor with demonstrated antiviral activity against herpes simplex virus 1 (HSV-1) and several other herpesviruses. However, the stages of HSV-1 replication inhibited by NFV have not been explored. In this study, we investigated the effects of NFV on capsid assembly and envelopment. We confirmed the inhibitory effects of NFV on HSV-1 replication by plaque assay and found that treatment with NFV did not affect capsid assembly, activity of the HSV-1 maturational protease, or formation of DNA-containing capsids in the nucleus. Confocal and electron microscopy studies showed that these capsids were transported to the cytoplasm but failed to complete secondary envelopment and subsequent exit from the cell. Consistent with the microscopy results, a light-scattering band corresponding to enveloped virions was not evident following sucrose gradient rate-velocity separation of lysates from drug-treated cells. Evidence of a possibly related effect of NFV on viral glycoprotein maturation was also discovered. NFV also inhibited the replication of an HSV-1 thymidine kinase mutant resistant to nucleoside analogues such as acyclovir. Given that NFV is neither a nucleoside mimic nor a known inhibitor of nucleic acid synthesis, this was expected and suggests its potential as a coinhibitor or alternate antiviral therapeutic agent in cases of resistance.

Original languageEnglish (US)
Pages (from-to)5455-5461
Number of pages7
JournalJournal of Virology
Volume88
Issue number10
DOIs
StatePublished - 2014

Fingerprint

Nelfinavir
Human herpesvirus 1
Human Herpesvirus 1
capsid
Capsid
nucleosides
thymidine kinase
Virus Replication
Nucleosides
Antiviral Agents
light scattering
Human immunodeficiency virus 1
proteinase inhibitors
virion
nucleic acids
glycoproteins
HIV Protease Inhibitors
Nucleic Acid Synthesis Inhibitors
microscopy
electron microscopy

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Nelfinavir inhibits maturation and export of herpes simplex virus 1. / Kalu, Nene N.; Desai, Prashant; Shirley, Courtney M.; Gibson, D Wade; Dennis, Phillip A.; Ambinder, Richard F.

In: Journal of Virology, Vol. 88, No. 10, 2014, p. 5455-5461.

Research output: Contribution to journalArticle

Kalu, Nene N. ; Desai, Prashant ; Shirley, Courtney M. ; Gibson, D Wade ; Dennis, Phillip A. ; Ambinder, Richard F. / Nelfinavir inhibits maturation and export of herpes simplex virus 1. In: Journal of Virology. 2014 ; Vol. 88, No. 10. pp. 5455-5461.
@article{c35f03a149474b479a0f9fab7c16d147,
title = "Nelfinavir inhibits maturation and export of herpes simplex virus 1",
abstract = "Nelfinavir (NFV) is an HIV-1 protease inhibitor with demonstrated antiviral activity against herpes simplex virus 1 (HSV-1) and several other herpesviruses. However, the stages of HSV-1 replication inhibited by NFV have not been explored. In this study, we investigated the effects of NFV on capsid assembly and envelopment. We confirmed the inhibitory effects of NFV on HSV-1 replication by plaque assay and found that treatment with NFV did not affect capsid assembly, activity of the HSV-1 maturational protease, or formation of DNA-containing capsids in the nucleus. Confocal and electron microscopy studies showed that these capsids were transported to the cytoplasm but failed to complete secondary envelopment and subsequent exit from the cell. Consistent with the microscopy results, a light-scattering band corresponding to enveloped virions was not evident following sucrose gradient rate-velocity separation of lysates from drug-treated cells. Evidence of a possibly related effect of NFV on viral glycoprotein maturation was also discovered. NFV also inhibited the replication of an HSV-1 thymidine kinase mutant resistant to nucleoside analogues such as acyclovir. Given that NFV is neither a nucleoside mimic nor a known inhibitor of nucleic acid synthesis, this was expected and suggests its potential as a coinhibitor or alternate antiviral therapeutic agent in cases of resistance.",
author = "Kalu, {Nene N.} and Prashant Desai and Shirley, {Courtney M.} and Gibson, {D Wade} and Dennis, {Phillip A.} and Ambinder, {Richard F}",
year = "2014",
doi = "10.1128/JVI.03790-13",
language = "English (US)",
volume = "88",
pages = "5455--5461",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Nelfinavir inhibits maturation and export of herpes simplex virus 1

AU - Kalu, Nene N.

AU - Desai, Prashant

AU - Shirley, Courtney M.

AU - Gibson, D Wade

AU - Dennis, Phillip A.

AU - Ambinder, Richard F

PY - 2014

Y1 - 2014

N2 - Nelfinavir (NFV) is an HIV-1 protease inhibitor with demonstrated antiviral activity against herpes simplex virus 1 (HSV-1) and several other herpesviruses. However, the stages of HSV-1 replication inhibited by NFV have not been explored. In this study, we investigated the effects of NFV on capsid assembly and envelopment. We confirmed the inhibitory effects of NFV on HSV-1 replication by plaque assay and found that treatment with NFV did not affect capsid assembly, activity of the HSV-1 maturational protease, or formation of DNA-containing capsids in the nucleus. Confocal and electron microscopy studies showed that these capsids were transported to the cytoplasm but failed to complete secondary envelopment and subsequent exit from the cell. Consistent with the microscopy results, a light-scattering band corresponding to enveloped virions was not evident following sucrose gradient rate-velocity separation of lysates from drug-treated cells. Evidence of a possibly related effect of NFV on viral glycoprotein maturation was also discovered. NFV also inhibited the replication of an HSV-1 thymidine kinase mutant resistant to nucleoside analogues such as acyclovir. Given that NFV is neither a nucleoside mimic nor a known inhibitor of nucleic acid synthesis, this was expected and suggests its potential as a coinhibitor or alternate antiviral therapeutic agent in cases of resistance.

AB - Nelfinavir (NFV) is an HIV-1 protease inhibitor with demonstrated antiviral activity against herpes simplex virus 1 (HSV-1) and several other herpesviruses. However, the stages of HSV-1 replication inhibited by NFV have not been explored. In this study, we investigated the effects of NFV on capsid assembly and envelopment. We confirmed the inhibitory effects of NFV on HSV-1 replication by plaque assay and found that treatment with NFV did not affect capsid assembly, activity of the HSV-1 maturational protease, or formation of DNA-containing capsids in the nucleus. Confocal and electron microscopy studies showed that these capsids were transported to the cytoplasm but failed to complete secondary envelopment and subsequent exit from the cell. Consistent with the microscopy results, a light-scattering band corresponding to enveloped virions was not evident following sucrose gradient rate-velocity separation of lysates from drug-treated cells. Evidence of a possibly related effect of NFV on viral glycoprotein maturation was also discovered. NFV also inhibited the replication of an HSV-1 thymidine kinase mutant resistant to nucleoside analogues such as acyclovir. Given that NFV is neither a nucleoside mimic nor a known inhibitor of nucleic acid synthesis, this was expected and suggests its potential as a coinhibitor or alternate antiviral therapeutic agent in cases of resistance.

UR - http://www.scopus.com/inward/record.url?scp=84899067359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899067359&partnerID=8YFLogxK

U2 - 10.1128/JVI.03790-13

DO - 10.1128/JVI.03790-13

M3 - Article

C2 - 24574416

AN - SCOPUS:84899067359

VL - 88

SP - 5455

EP - 5461

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 10

ER -